Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Frontline Oral Arsenic Trioxide-based Induction in Newly Diagnosed Acute Promyelocytic Leukaemia

NCT04687176 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT04687176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04687176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Frontline Oral Arsenic Trioxide-based Induction in Newly Diagnosed Acute Promyelocytic Leukaemia
Lead sponsor
The University of Hong Kong
Phase
Phase 2
Overall status
Recruiting
Start date
January 1, 2021
Completion date
June 30, 2026
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute promyelocytic leukemia